Nrf2 overexpression or Keap1 knockout can inhibit ferroptosis, accelerate the proliferation of glioma cells, and reduce the survival rate of tumor patients, suggesting a potential target for tumor treatment (Sartori et al., 2010). The gene discussed is KEAP1; the disease is neoplasm.